The Fund aims to provide a combination of income and long term capital growth.
Name | % Net Assets |
---|---|
HSBC Holdings | 8.8% |
Royal Dutch Shell | 7.0% |
BP | 6.8% |
Glaxosmithkline | 6.8% |
Travis Perkins | 5.1% |
Vodafone Group | 4.6% |
Astrazeneca | 4.3% |
UNILEVER | 4.1% |
SIGNET JEWELERS LTD | 3.8% |
British American Tobacco | 2.9% |
Key | % Net Assets |
---|---|
HSBC Holdings | 8.8% |
Royal Dutch Shell | 7.0% |
BP | 6.8% |
Glaxosmithkline | 6.8% |
Other | 70.6% |
Date | 21-Nov-2024 |
---|---|
NAV | 629.67p |
Currency | GBP |
Change | -0.100p |
% | -0.02% |
YTD change | 69.56p |
YTD % | 12.42% |
Fund Inception | 02/10/1978 |
---|---|
Fund Manager | Alastair Mundy |
TER | 1.60 (30-Sep-2011) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | £100 |
Savings | £100 |
Charges | |
---|---|
Initial | 4.50% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.17 |
You are here: research